OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
Kendall Woodlief, Mia I Allen, Jeremy C. Cornelissen, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1716-1723
Closed Access | Times Cited: 9
Kendall Woodlief, Mia I Allen, Jeremy C. Cornelissen, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1716-1723
Closed Access | Times Cited: 9
Showing 9 citing articles:
IUPHAR Review: New strategies for medications to treat substance use disorders
Iván D. Montoya, Nora D. Volkow
Pharmacological Research (2024) Vol. 200, pp. 107078-107078
Open Access | Times Cited: 7
Iván D. Montoya, Nora D. Volkow
Pharmacological Research (2024) Vol. 200, pp. 107078-107078
Open Access | Times Cited: 7
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
James E. Barrett, Aryan Shekarabi, Saadet Inan
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1062-1118
Open Access | Times Cited: 12
James E. Barrett, Aryan Shekarabi, Saadet Inan
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1062-1118
Open Access | Times Cited: 12
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 4
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 4
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder
Matthew L. Banks, Jon E. Sprague
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
Matthew L. Banks, Jon E. Sprague
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
A comparison of the reinforcing strength of cocaethylene and cocaine in monkeys responding under progressive-ratio and concurrent choice schedules of reinforcement
Mia I Allen, Bernard Johnson, Michael A. Nader
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110952-110952
Open Access | Times Cited: 6
Mia I Allen, Bernard Johnson, Michael A. Nader
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110952-110952
Open Access | Times Cited: 6
A novel opioid/pramipexole combination treatment for the management of acute pain: a pilot study
Cara Girardi, Joseph P. Duronio, Ryan Patton, et al.
Frontiers in Pain Research (2024) Vol. 5
Open Access
Cara Girardi, Joseph P. Duronio, Ryan Patton, et al.
Frontiers in Pain Research (2024) Vol. 5
Open Access
Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement
Mia I Allen, Evan Lewis, Jianjing Cao, et al.
Drug and Alcohol Dependence (2024) Vol. 265, pp. 112494-112494
Closed Access
Mia I Allen, Evan Lewis, Jianjing Cao, et al.
Drug and Alcohol Dependence (2024) Vol. 265, pp. 112494-112494
Closed Access
The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature
Alejandra Pulido-Saavedra, A Borelli, Razi Kitaneh, et al.
Expert Opinion on Pharmacotherapy (2024), pp. 1-14
Closed Access
Alejandra Pulido-Saavedra, A Borelli, Razi Kitaneh, et al.
Expert Opinion on Pharmacotherapy (2024), pp. 1-14
Closed Access
Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
Samantha Chong, Sandra D. Comer
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1703-1704
Closed Access
Samantha Chong, Sandra D. Comer
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1703-1704
Closed Access
